Suppr超能文献

结节性多动脉炎并发早期腔隙性卒中:血栓性微血管病

Early lacunar strokes complicating polyarteritis nodosa: thrombotic microangiopathy.

作者信息

Reichart M D, Bogousslavsky J, Janzer R C

机构信息

Department of Neurology, University Hospital of Lausanne, Switzerland.

出版信息

Neurology. 2000 Feb 22;54(4):883-9. doi: 10.1212/wnl.54.4.883.

Abstract

OBJECTIVE

To determine the patterns and mechanisms of polyarteritis nodosa (PAN)-associated strokes (PANAS).

BACKGROUND

Strokes are reputed to be rare complications of PAN and to occur at a late stage (2 to 3 years). The cause of stroke is unknown but may be related either to atherosclerosis-like occlusive vasculopathy, caused possibly by hypertension or corticosteroid (CS) use, or to vasculitic arterial occlusion.

METHODS

Clinical and radiologic patterns, latencies, and current therapy at onset in 15 PANAS patients (4 of the authors' and 11 published cases) were analyzed.

RESULTS

A lacunar stroke syndrome (11/15 cases, 73%) was the most frequent stroke pattern in PANAS (multiple, small, deep infarcts in 6, [55%], pontine lacunae in 3 [27%], and leukoaraiosis in 2 [18%]), followed by pure lobar hematoma and bilateral, possibly cardioembolic, large ischemic infarcts (2 cases each). A stroke latency shorter than that previously established (within 8 months in 73% of cases; mean latency, 6.5 months) and a close relationship between the use of CS and stroke in PAN also were found. Of the 77% of first-time or recurrent lacunar strokes that developed despite CS therapy, 80% appeared within 6 months and 50% within 3 weeks of CS initiation.

CONCLUSION

Early lacunar stroke syndrome, related to deep small- or pontine-penetrating artery thrombotic microangiopathy rather than vasculitis, was the most frequent PANAS pattern. This vasculopathy may be aggravated by corticosteroid (CS) therapy enhancement of either platelet thromboxane A2 production or arterial wall fibrosis. Thus, antiplatelet drugs in association with CS may be advisable for preventing stroke occurrence or recurrence in PAN.

摘要

目的

确定结节性多动脉炎(PAN)相关卒中(PANAS)的模式和机制。

背景

卒中被认为是PAN罕见的并发症,且发生在疾病后期(2至3年)。卒中的病因尚不清楚,但可能与动脉粥样硬化样闭塞性血管病变有关,这可能是由高血压或使用皮质类固醇(CS)引起的,也可能与血管炎性动脉闭塞有关。

方法

分析了15例PANAS患者(作者的4例和11例已发表病例)的临床和放射学模式、发病潜伏期及发病时的当前治疗情况。

结果

腔隙性卒中综合征(11/15例,73%)是PANAS中最常见的卒中模式(6例为多发性、小而深的梗死灶,[55%];3例为脑桥腔隙,[27%];2例为白质疏松,[18%]),其次是单纯脑叶血肿和双侧、可能为心源性栓塞的大面积缺血性梗死(各2例)。还发现卒中潜伏期比先前确定的更短(73%的病例在8个月内;平均潜伏期为6.5个月),并且在PAN中CS的使用与卒中之间存在密切关系。在尽管接受CS治疗仍发生的首次或复发性腔隙性卒中中,77%的病例在CS开始使用后6个月内出现,50%在3周内出现。

结论

与深部小动脉或脑桥穿通动脉血栓性微血管病而非血管炎相关的早期腔隙性卒中综合征是最常见的PANAS模式。这种血管病变可能因皮质类固醇(CS)治疗增强血小板血栓素A2生成或动脉壁纤维化而加重。因此,联合使用抗血小板药物和CS可能有助于预防PAN患者卒中的发生或复发。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验